Shopping Cart
Remove All
Your shopping cart is currently empty
Davoceticept (ALPN-202; CD80 vIgD-Fc), a monoclonal antibody that targets CTLA-4, consists of the (1-107) fragment of CD80 fused to the IGHG1 Fc domain via a peptidyl linker and is typically produced in CHO (Chinese Hamster Ovary) cells [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Davoceticept (ALPN-202; CD80 vIgD-Fc), a monoclonal antibody that targets CTLA-4, consists of the (1-107) fragment of CD80 fused to the IGHG1 Fc domain via a peptidyl linker and is typically produced in CHO (Chinese Hamster Ovary) cells [1]. |
| Synonyms | CD80 vIgD-Fc, ALPN-202 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2307144-64-3 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.